Editor's Note The bipartisan Medical Supply Chain Resiliency Act would grant the president expanded authority to negotiate trade deals and modify tariffs on medical goods, according to a March 14 report from Fierce Healthcare. The bill, backed by pharmaceutical and healthcare industry groups, aims to strengthen the US medical supply…
Editor's Note The US Food and Drug Administration (FDA) has deemed Smiths Medical’s recall of Proport Plastic Implantable Ports a Class 1, the most severe designation indicating serious risk of injury or death. The devices are designed for repeated venous access for injections, infusions, and/or blood samples. According to the…
Editor's Note Endovascular devices used to block aneurysm blood flow are the subject of the latest recall to be designated Class 1—the most severe designation indicating serious risk of injury or death—by the US Food and Drug Administration (FDA). As detailed in the agency’s March 18 announcement, Medtronic Neurovascular is…
Editor's Note Chief data officer (CDO) is a fast-growing C-suite role across the economy, with the notable exception of healthcare. The reasons why might be surprising: these roles have already been filled. Rather than growing, they are evolving. That’s the primary message of a March 4 report in Becker’s Hospital…
Editor's Note The Joint Commission has announced UNIFY 2025: Convening for Quality, a national event set for September 16-17, 2025, in Washington, DC. The two-day gathering will bring together healthcare leaders and policymakers to address critical challenges in patient safety and healthcare quality. According to the announcement, the event will…
Editor's Note Although hospitals are already integrating artificial intelligence (AI), nurses warn that the technology may undermine their expertise and compromise patient care, The Associated Press (AP) reported March 16. The push for AI in healthcare stems from widespread nursing shortages. More than 100,000 nurses left the workforce during the…
Editor's Note Miniaturized pacemakers implanted in neonates and infants have demonstrated reliable performance for up to two years, with no unexpected device failures, according to a March 11 article in Healio. The research, published in Circulation: Arrhythmia and Electrophysiology, suggests that these modified pacemakers could offer a viable alternative for…
Editor's Note Preoperative use of GLP-1 receptor agonists was not significantly associated with an increased risk of aspiration pneumonia or acute respiratory failure after surgery, according to a March 4 report in MedPage Today. The article focuses on a retrospective cohort study of over 366,000 surgical patients found no meaningful…
Editor's Note An Australian man lived for 100 days with an artificial titanium heart, the longest duration recorded for a patient using the device, according to a March 12 report from CNN. The breakthrough marks a significant step toward using total artificial hearts as a long-term solution for patients with…
Editor's Note A systematic review found no strong evidence that compliance with the CMS Severe Sepsis and Septic Shock Management Bundle (SEP-1) reduces mortality, raising questions about its inclusion in hospital performance measures, according to a February 19 report from the University of Minnesota’s Center for Infectious Disease Research and…